Palivizumab injection (Synagis), an RSV prevention therapy for children, is being discontinued and will no longer be available as of December 31, 2025.

In babies, RSV is a common cause of a type of chest infection called bronchiolitis. Last week, the UK Health Security Agency ...

RSV usually only has mild symptoms, but it can lead to breathing problems in the most vulnerable infants. The vaccine is ...

Respiratory syncytial virus vaccine uptake was low among older veterans, with disparities observed across demographic and social risk factors.

The NHS has warned of a 'serious virus' after a surge in cases of respiratory syncytial virus (RSV) in Australia. Here's ...

How you can make sure you get your RSV vaccine this winterThe UK is the first country to offer a RSV vaccine to help save the ...

RSV hospitalization was associated with increased risk for new CVEs and worsening of preexisting cardiovascular conditions.

For newborns and infants, whose immune systems are still developing, and airways are small, RSV can quickly become serious.

Nirsevimab is effective for protecting infants against respiratory syncytial virus (RSV)-associated lower respiratory tract ...

We thank Jeffrey Wagner for his comments on our real-world investigation of respiratory syncytial virus (RSV) vaccine effectiveness among adults aged 60 years and older in the USA.1 In response to his ...

Children under 2 years of age are at highest risk for getting critically ill from the flu or RSV and requiring intensive care. Currently, doctors can only provide breathing support for severe flu or ...

Officials estimated that 228 fewer babies younger than 3 months older were hospitalized for serious RSV infection during the peak of the season, a number they hope will increase as more women are ...